Group One Trading, L.P. Macrogenics Inc Transaction History

Group One Trading, L.P.

$3.01 Billion
Q2 2024

A detailed history of Group One Trading, L.P. transactions in Macrogenics Inc stock. As of the latest transaction made, Group One Trading, L.P. holds 16,889 shares of MGNX stock, worth $70,764. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,889

Previous 32,548 48.11%

Holding current value

$70,764

Previous $479,000 85.18%

% of portfolio

0.0%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.31 - $18.51 $51,831 - $289,848	-15,659 Reduced 48.11%	16,889 $71,000
Q1 2024 May 10, 2024	BUY	$9.77 - $21.47 $214,627 - $471,652	21,968 Added 207.64%	32,548 $479,000
Q4 2023 Feb 14, 2024	BUY	$4.48 - $10.11 $28,703 - $64,774	6,407 Added 153.53%	10,580 $101,000
Q3 2023 Nov 09, 2023	SELL	$4.48 - $6.19 $117,824 - $162,797	-26,300 Reduced 86.31%	4,173 $19,000
Q2 2023 Aug 09, 2023	SELL	$4.62 - $7.54 $8,523 - $13,911	-1,845 Reduced 5.71%	30,473 $163,000
Q1 2023 May 12, 2023	BUY	$4.82 - $7.24 $155,772 - $233,982	32,318 New	32,318 $231,000
Q2 2022 Aug 11, 2022	BUY	$2.25 - $9.99 $207 - $919	92 New	92 $0
Q4 2021 Feb 11, 2022	SELL	$15.91 - $21.88 $279,156 - $383,906	-17,546 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$19.74 - $28.7 $189,188 - $275,060	9,584 Added 120.37%	17,546 $367,000
Q2 2021 Aug 10, 2021	BUY	$20.49 - $35.63 $140,315 - $243,994	6,848 Added 614.72%	7,962 $214,000
Q1 2021 May 12, 2021	BUY	$18.99 - $33.2 $21,154 - $36,984	1,114 New	1,114 $35,000
Q2 2020 Aug 13, 2020	SELL	$5.2 - $29.12 $73,153 - $409,660	-14,068 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$4.28 - $12.11 $60,211 - $170,363	14,068 New	14,068 $82,000
Q3 2019 Nov 12, 2019	SELL	$12.44 - $17.48 $126,614 - $177,911	-10,178 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$14.51 - $19.71 $274,166 - $372,420	-18,895 Reduced 64.99%	10,178 $173,000
Q1 2019 May 13, 2019	BUY	$11.11 - $25.6 $318,412 - $733,696	28,660 Added 6939.47%	29,073 $523,000
Q4 2018 Feb 06, 2019	BUY	$11.75 - $21.42 $4,852 - $8,846	413 New	413 $5,000
Q1 2018 May 11, 2018	SELL	$18.89 - $32.46 $22,913 - $39,373	-1,213 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$16.19 - $20.3 $23,281 - $29,191	-1,438 Reduced 54.24%	1,213 $23,000
Q3 2017 Nov 15, 2017	SELL	$15.52 - $18.94 $20,936 - $25,550	-1,349 Reduced 33.73%	2,651 $49,000
Q2 2017 Aug 14, 2017	BUY	N/A	4,000	4,000 $70,000

Others Institutions Holding MGNX

# of Institutions

150

Shares Held

60.4M

Call Options Held

218K

Put Options Held

259K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $258M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Macrogenics Inc Transaction History